Nov 15 (Reuters) - Capitol Health Ltd (CAJ) -
- Ebitda of group for December 2016 half year is likely to be in range of $7.7m to $8.2m
- Capitol's revenue was below expectations and likely to result in revenue for half year in range of $79 to $80m
- Board is also undertaking a review of non-core investments which is expected to be complete by end of half
- Capital expenditure has also been reduced resulting in an expected spend below $5m for 2017 financial year
Add to My Watchlist
What is My Watchlist?